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 Disfluencies as a consequence of acquired stuttering can arise subsequent to 
neurological trauma, psychological stress, and medication use. Acquired stuttering 
presents as various clinical pictures depending on the etiology of the disfluencies. This 
leads to difficulties in the assessment, and ultimately treatment, process. Similarly, the 
onset, characteristics, associated symptomatology, and assessment processes of the 
disorder differ between individual cases. Thus, there is dispute in the current literature on 
the characteristics and diagnostic procedures involved with acquired stuttering. This 
report offers a comprehensive review of the nature and assessment of acquired stuttering, 
serving to compile and organize the current views of the disorder.  
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 Stuttering is a speech disorder characterized by interruptions in fluent speech, 
tension, and arrhythmic speech. Secondary behaviors (i.e. extraneous body movements or 
eye blinks), avoidance behaviors (i.e. word avoidance), and negative emotions associated 
with disfluent speech may accompany the stuttering.  The typical view of stuttering 
maintains the development of stuttering during childhood and the continuation of 
stuttering throughout adult life. For the purposes of this report, this type of stuttering will 
be referred to as organic stuttering, however this type of stuttering is also commonly 
referred to as developmental stuttering (Jones, Conture, & Walden, 2014; McDearmon, 
1968; Van Borsel, 2014). In less common circumstances, stuttering may present as a 
result of neurogenic injury, psychological trauma, or medicine use and is referred to as 
acquired stuttering. Similar to organic stuttering, acquired stuttering is a speech disorder 
characterized by disfluent speech and may be accompanied by the other stuttering 
characteristics. Individuals with acquired stuttering may show normal disfluencies 
(whole-word repetitions, phrase repetitions, revisions, interjections) as well as stuttering 
like disfluencies (sound and syllable repetitions, prolongations, blocks) (Guitar, 2013; 
Helm, Butler, & Canter, 1980; Theys, van Wieringen, & De Nil, 2008; Van Borsel & 
Taillieu, 2001; Yairi & Ambrose, 2013). 
Organic stuttering and acquired stuttering share many of the same characteristics 
and may be homologous in primary and secondary stuttering behaviors, necessitating the 
examination of the disorder to differentiate between the two types of stuttering. The age 
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and circumstance around the onset of stuttering provide valuable information to the 
examination and evaluation of acquired stuttering. While organic stuttering presents in 
childhood, acquired stuttering typically presents after the developmental years (Duffy & 
Baumgartner, 1997; Krishnan & Tiwari, 2013; Theys, van Wieringen, Tuyls, & De Nil, 
2009; Van Riper, 1964). 
The etiologies of stuttering, including genetic factors, neurologic trauma, 
psychological stress, and medication use, each contribute to the unique presentation of 
acquired stuttering types. Genetic factors are hypothesized in acquired stuttering, but 
have not yet been reported to impact a significant portion of those with acquired 
stuttering. Neurologic trauma is a nonorganic, cerebral cause of acquired neurogenic 
stuttering that occurs after central nervous system damage (Theys et al., 2008; Van 
Borsel, 2014). Psychogenic stuttering is a form of acquired stuttering caused by 
psychological or emotional stress that cause disfluent speech (Duffy & Baumgartner, 
1997; Theys et al., 2009; Ward, 2010). Medicine induced stuttering is caused by the 
presence, or excess, of medication which elicits neurochemical responses manifested as 
disfluencies (Lundgren, Helm-Estabrooks, & Klein, 2010; Van Borsel, 2014). Examining 
the characteristics of acquired stuttering lends valuable information on the etiology of 
stuttering. 
Associated symptomatology is often present alongside acquired stuttering. 
Aphasia, dysarthria, and apraxia are common conditions that present simultaneously to 
stuttering and may contribute to or impact stuttering presentation. Different traumatic 
experiences lead to different presentations of comorbid symptomatology. Acquired 
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stuttering commonly occurs in individuals with multifaceted communication problems. 
Examining the complex nature of communication disorders associated with neurological, 
psychological, or medicine induced trauma as they relate to acquired stuttering aids in 
assessment and treatment processes (Helm et al., 1980; Krishnan & Tiwari, 2011; Theys 
et al., 2008). 
 Assessment of acquired stuttering is an involved process contingent upon the 
presence of characteristics of acquired stuttering types and response to trial therapy. 
General assessment procedures that are used in organic stuttering should be administered 
during an acquired stuttering evaluation. Examining characteristics present in an 
individual with acquired stuttering, while specifically looking at the circumstance around 
the onset of stuttering and the primary and secondary characteristics of stuttering, aid in 
the evaluation process. Response to trial therapy is a notable diagnostic marker in 
acquired stuttering. Neurogenic stuttering tends to persist despite fluency treatment, 
unless the underlying neurologic trauma is remitted. Those with psychogenic stuttering 
have been reported to have remarkable recovery after fluency or psychiatric treatment. 
Similarly, medicine induced stuttering tends to resolve with treatment including 
discontinuing the medicine suspected of inducing disfluencies. Thus, the circumstance 
under which stuttering improves or does not improve is a telling feature of acquired 
stuttering assessment (Guitar, 2013; Krishnan & Tiwari, 2013; Lebrun, Bijleveld, & 
Rousseau, 1990; Van Borsel, 2014; Ward, 2010). 
Finally, malingered stuttering is intentional stuttering for the purpose of 
benefitting from claiming the disorder. Assessing malingered stuttering is an involved 
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process that includes understanding common stuttering characteristics and evaluating 
their presence in a person with possible malingered stuttering. Though malingered 
stuttering is not a genuine form of stuttering, assessing for feigned disfluencies is an 
important skill for Speech Language Pathologists because of the potential disguise as 
acquired or organic stuttering (Bloodstein, 1988; Seery, 2005; Shirkey, 1987). 
The following report explains the nature, characteristics, associated 
symptomatology, and assessment of acquired studying. Neurogenic, psychogenic, and 





Onset of Acquired Stuttering 
The onset of acquired stuttering ranges from childhood to adulthood. Acquired 
stuttering can appear at any age after a neurological, psychological, or medicine related 
event, though is more likely to occur during adulthood than childhood (Krishnan & 
Tiwari, 2013; Theys et al., 2009; Van Borsel, 2014; Van Riper, 1964). The onset of 
acquired stuttering commonly happens suddenly and invariably happens subsequent to a 
period of time when stuttering was not present (Sabillo, Samala, & Ciocon, 2012; Van 
Riper, 1964; Ward, 2010).  
Organic stuttering initially presents during the language development year, 
usually between 2 and 6 years old, and begins to appear gradually (Yairi & Ambrose, 
2013). Therefore, stuttering that appears after the developmental language years is likely 
to be acquired stuttering (Chang, Erickson, Ambrose, Hasegawa-Johnson, & Ludlow, 
2008; Yairi, 2006). However, neurogenic injury, psychological trauma, or medicine-
induced neuronal damage can occur at any age, therefore acquired stuttering can occur 
during the developmental years if trauma occurs during these years (Perez, Gubser-
mercati, & Davidoff, 1996). Additionally, the onset of acquired stuttering can occur later 
than the initial trauma that caused the stuttering, as seen as a delayed manifestation of 
disfluencies (Attanasio, 1987). Thus, viewing the circumstances around and before the 





Etiologies of Acquired Stuttering 
Acquired stuttering and organic stuttering are both multifactorial disorders and 
both can precede diverse etiologies. Acquired stuttering results from different types of 
traumatic incidents, including neurogenic, psychogenic, or drug-induced trauma. These 
three causes make up the majority of acquired stuttering occurrences (Bhatnagar & 
Buckingham, 2010; Van Borsel, 2014). Organic stuttering can result from multiple 
factors that contribute to stuttering development, however unlike acquired stuttering, 
there is no discernable cause of organic stuttering. Contributing factors of organic 
stuttering include genetics, language disorders or delays (Ntourou, Conture, & Lipsey, 
2011; Yaruss, LaSalle, & Conture, 1998), and neurophysiology (Bhatnagar & 
Buckingham, 2010).  
Though the etiologies of acquired stuttering and organic stuttering differ, the two 
disorders share a commonality of factors that exacerbate disfluencies. These factors 
include stressful demands for communication that stem from lifestyle and environmental 
circumstances. Communication demands may exceed a person’s capacity for 
communication, resulting in a breakdown of speech that is represented as disfluencies 
(Adams, 1990; Starkweather & Gottwald, 1990).  Nevertheless, the factors that 
exacerbate disfluencies are not interchangeable with the etiologies of stuttering in either 
disorder. Both acquired and organic stuttering may present alongside, but be independent 





GENETIC COMPONENTS OF ACQUIRED AND ORGANIC STUTTERING 
Acquired stuttering has not yet been observed to have a significant genetic 
component. Organic stuttering, however, has a significant genetic component and 
familial link. Children with family members who stutter, are more likely to develop a 
stutter (Duffy & Baumgartner, 1997; Kraft & Yairi, 2011). Individuals who exhibit 
acquired stuttering may have a genetic predisposition to stuttering in which an aspect of 
their neuroanatomy increases the likelihood that they will acquire stuttering later in life. 
Those who appear to have acquired stuttering may be covert stutterers and have hidden 
their organic stuttering throughout their lifetime. Additionally, neurological trauma, 
psychological trauma, or medication may have an adverse effect on organic stuttering in 
which disfluencies recur, change, or increase in severity (Theys et al., 2008; Van Borsel, 
2002). After trauma to the brain or specific medication use, disfluencies may become 
evident in these individuals. Discriminating between the presence of genetic 
predispositions for stuttering or covert developmental stuttering that resurfaces is a 
difficult task and one that warrants a comprehensive profile of the individual (Grant, 
Biousse, Cook, & Newman, 1999; Riggs, Nelson, & Lanham, 1983). 
Acquired stuttering can be seen in any gender and is as equally likely to occur in 
women and men. Gender differences may play a role in acquired stuttering incidence if a 
particular gender is more likely to sustain neurogenic trauma that results in stuttering. 
However gender differences are not inherently responsible for disparities in stuttering 
incidence among men and women (Duffy & Baumgartner, 1997). In contrast, organic 
 
 8 
stuttering is 4 times more likely to be seen in males than in females (Craig, Hancock, 
Tran, Craig, & Peters, 2002; Yairi & Ambrose, 2013). 
 
NEUROGENIC STUTTERING 
 Neurogenic stuttering is a type of acquired stuttering that results from nonorganic 
damage to the central nervous system (CNS). Increases in stuttering as a result of CNS 
damage are associated with many lesion sites. Cerebral damage locations have been 
reported to be unilateral in either hemisphere, bilateral, focal, and diffuse. However 
bilateral and diffuse lesions tend to produce more profound and long-term fluency 
difficulties. Damage that causes stuttering has also been reported in the corpus callosum, 
in the cerebellum, in the brainstem, and in the frontal, temporal, occipital and parietal 
lobe. However, acquired neurogenic stuttering predominantly corresponds with damage 
to the left anterior portion of the brain, an area commonly associated with language. 
Specific causes of neurologic damage include traumatic brain injury, seizures, 
encephalitis, Parkinson’s disease, neurodegenerative disease, tumor, and stroke (Grant et 
al., 1999; Krishnan & Tiwari, 2013; Lebrun et al., 1990; Sabillo et al., 2012; Tippett & 
Siebens, 1991; Van Borsel, 2002). 
Neurogenic stuttering can occur at any age after a neurogenic event. Neurogenic 
stuttering has been reported in a range of ages, from children 3 years old due to damage 
from rotavirus and encephalitis, to adults 93 years old due to damage from stroke, 
neurodegenerative disease, or brain injury. Most commonly, however, acquired 
neurogenic stuttering occurs in adulthood (Theys et al., 2009). In addition to stuttering 
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that first appears after a neurological event, damage from neurologic events can 
compound organic stuttering. Disfluencies from organic stuttering can recur, worsen, or 
change after neurological trauma (Rentschler, Driver, & Callaway, 1984; Theys et al., 
2008, 2009). 
 Disfluencies vary among individuals with neurogenic stuttering. Stuttering 
frequency has been reported to be present in 3% to 50% of words in different individuals. 
The majority of individuals present with sound repetitions, syllable repetitions, and 
blocks during speech, however whole word repetitions and prolongations have also been 
reported. Disfluencies are largely present on both content and function words, differing 
notably from organic stuttering, which largely involves disfluencies on content words. 
Widely, patients are noted to stutter throughout various speech tasks, however some 
present with stuttering only on spontaneous speech. Secondary behaviors, including facial 
tension, body movements, and avoidance behaviors have been observed to vary between 
individuals as well. Additionally, emotional reactions and experiences related to 
stuttering, including frustration, irritation, fear, anger, and anxiety, are reported to differ. 
A link between site of neurological trauma and disfluency loci within a word or stuttering 
behaviors has not been identified; trauma to the same area in the CNS may yield very 
different clinical pictures. Altogether, disfluencies and secondary characteristics of those 
with acquired stuttering vary significantly despite similarities in CNS damage (Theys et 




Neurogenic stuttering typically begins close in time to the time of neurologic 
insult. Disfluencies commonly appear within one week of neurogenic injury. However, 
stuttering has been reported to appear a few weeks to a few months after the injury, with 
longer durations between damage and disfluency onset occurring more rarely (Theys et 
al., 2008; Van Borsel, 2002). When neurogenic stuttering does not begin close to the time 
of neurological insult, disfluencies are typically related to seizure disorders or epilepsy. 
Disfluencies may appear as seizures become more complex, severe, or frequent. 
Additionally, stuttering may begin after subsequent injuries. Disfluencies have been 
reported to appear after a second stroke or brain injury, but may be related to both 
traumatic incidents (Helm et al., 1980).  
Acquired stuttering has been reported to occur with concomitant neurologic 
problems. The nature of the disorder permits related complications because brain trauma 
typically yields difficulties in multiple realms and is affiliated with multiple side effects. 
Right and left hemiparesis, headaches, tremors, and incoordination are among the 
commonly co-occurring difficulties (Duffy & Baumgartner, 1997; Theys et al., 2008). 
 
PSYCHOGENIC STUTTERING 
Psychogenic stuttering is an acquired fluency disorder related to psychological 
trauma. Disfluencies in those with psychogenic stuttering are a physical manifestation of 
acute or chronic emotional problems. The criteria typically used to classify a psychogenic 
stutter are a change in speech patterns that include disfluencies and are indicative of 
stuttering, onset of stuttering close in proximity to onset of psychological factors, and no 
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organic stuttering evidence. History of mental health issues and abnormal secondary 
behaviors are additional factors that are frequently reported in those suspected of 
psychogenic stuttering. These features are common in those with psychogenic stuttering, 
however they have been disputed in the literature and the presence of the characteristics 
is not invariably indicative of psychogenic stuttering (Duffy & Baumgartner, 1997; Theys 
et al., 2009; Ward, 2010). Organic stuttering, however, may be exacerbated during 
emotional turmoil (i.e. getting nervous during a presentation and stuttering more) but the 
emotional problems do not cause the stuttering.  
Psychiatric trauma associated with psychogenic stuttering can be from any form 
of psychological problem. Common psychiatric diagnoses associated with psychogenic 
stuttering are conversion reaction, anxiety, depression, personality disorder, and post 
traumatic stress disorder. Combinations of psychiatric disorders have also been reported 
(Duffy & Baumgartner, 1997). Emotional stress unrelated to a psychiatric diagnosis has 
been reported to cause psychogenic stuttering. Psychogenic stuttering is not exclusive to 
those with mental health disorders. The events that may cause stuttering in an individual 
should be viewed as the person with stuttering perceives them; events may not appear 
likely to cause anxiety or stress but may be of particular importance to the individual and 
cause significant emotional trauma that spurs stuttering (Duffy & Baumgartner, 1997; 
Ward, 2010). 
Symptoms of psychogenic stuttering usually appear around the same time that the 
psychological stress occurs. However the symptoms may appear later than the psychiatric 
diagnosis at a seemingly random time or when the psychiatric problem was worsening 
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(Duffy & Baumgartner, 1997; Helm et al., 1980; Ward, 2010). Disfluencies vary in 
severity and exist despite normal cognition, vocabulary use, grammar and receptive 
language functions. Stuttering may develop in a similar manner as organic stuttering, 
gradually and continuing to develop over time, or there may not be noticeable changes 
after the initial presentation of disfluencies (Tippett & Siebens, 1991; Van Borsel, 2014). 
The length of time symptoms of psychogenic stuttering are evident also varies. The 
disorder can be considered chronic and last for a significant period of time (months or 
years), or it may subside quickly and last for only days (Duffy & Baumgartner, 1997). 
However, disfluencies routinely coincide with mental health status of an individual 
diagnosed with psychogenic stuttering. Stuttering may improve as mental health 
improves. Likewise, stuttering may worsen with increasing psychiatric demands. For 
example, if a person is experiencing depression they may be more susceptible to 
disfluencies during that time, or if a person is in a high anxiety situation, stuttering may 
increase (Helm et al., 1980; Tippett & Siebens, 1991). If the cause of psychogenic 
stuttering in an individual is chronic (i.e. a generalized psychiatric disorder), the 
individual may be prone to a longer recovery period as psychiatrics symptoms come and 
go. If the cause is unknown psychogenic (i.e. an idiopathic psychiatric disorder), the 
individual may be less likely to recover, and stuttering is less likely to improve with 
fluency or psychiatric techniques. However, progress is probable when the specific 
psychological cause is found and treated (Ward, 2010).  
Secondary behaviors exist in those with psychogenic stuttering but have been 
noted as atypical or “bizarre,” and not resembling those of organic stuttering. Abnormal 
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secondary behaviors noted have included unusual grammatical deviations and multiple 
repetitions of all phonemes with simultaneous body movements (Duffy & Baumgartner, 
1997; Lundgren et al., 2010). However, the literature reports some individuals with more 
typical secondary behaviors like eye squinting and facial tension (Theys et al., 2009). 
Those with psychogenic stuttering also have been reported to notice their stuttering, 
although not experience anxiety associated with their disfluencies. They often report 
feeling annoyance toward their stuttering or feeling concerned with their communication 
difficulties, but do not necessarily have stress or anxiety related to their stuttering (Theys 
et al., 2009; Ward, 2010).  
Psychogenic stuttering can happen as a result of an emotional reaction to 
neurological trauma. The two types of trauma (psychological and neurological) often 
occur together, warranting an understanding of the two types of stuttering. The 
disfluencies are not directly resulting from neurologic trauma itself. Rather, they are 
related to psychological stress that is associated with a neurologic event or that coexists 
with neurologic disease. Psychogenic stuttering may be rooted in a neurologic event that 
predisposes an individual to a fluency disorder, but the stuttering is spurred by 
psychogenic trauma subsequent to the neurologic event (i.e. a person may have a 
traumatic brain injury, after which no stuttering is noted. Years later, the person may 
notice stuttering while they are going though a divorce). In these cases, there is stronger 
evidence of a psychological origin of stuttering than a neurological origin (Duffy & 
Baumgartner, 1997; Helm et al., 1980; Van Borsel, 2014; Ward, 2010). Additionally, the 
interaction between psychogenic trauma and neurogenic trauma may cause stuttering 
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(Theys et al., 2008). Unquestionably, psychogenic stuttering can happen independent of 
any neurologic injury (Tippett & Siebens, 1991). 
Neurogenic diseases reported to have psychogenic implications, which may lead 
to stuttering, include epilepsy, stroke, degenerative disease, closed head injury, and 
encephalopathy/encephalitis. Many of these neurologic problems are associated with a 
significant period of emotional turmoil caused by medical complications, lifestyle 
changes, and uncertainty about future health and living conditions (Duffy & 
Baumgartner, 1997).  
 
MEDICINE INDUCED STUTTERING 
Medicine induced stuttering is a type of acquired fluency disorder in which 
stuttering necessarily accompanies the use of certain medications. The stuttering appears 
in people without a previous history of stuttering and they usually experience disfluencies 
that parallel the medication use. Disfluencies from medicine induced stuttering share a 
cause-and-effect relationship with medicine use. The type and severity of disfluencies 
that appears in medicine induced stuttering depend on the type and dosage of drug that 
caused the stuttering. Disfluencies from medication use may also manifest uniquely in 
each individual. Two people taking the same drug may both show signs of acquired 
stuttering, but exhibit distinct and different disfluencies or stuttering behaviors. 
Additionally, one person taking a drug may show signs of acquired stuttering, while 
another person does not (Lundgren et al., 2010; Van Borsel, 2002, 2014). 
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Acquired stuttering can be manipulated with drug dose. Disfluencies resulting 
from medications usually increase with increasing drug use and decrease with decreasing 
drug use (Christensen, Byerly, & McElroy, 1996; Grover, Verma, & Nebhinani, 2012; 
Murphy et al., 2015; Yadav, 2010). Presence of the drug in a person’s system and 
presence of stuttering are directly correlated. This is the only etiology of stuttering (from 
both acquired and developmental) that has a removable determinant: the medication. If 
the drug is removed, then the disfluencies should go away if the stuttering is truly 
medicine-induced. Additionally, if the same medicine is given to the same person again, 
the stuttering will likely reappear. This relationship exists because medications can cause 
perpetual neurochemical abnormalities that exist as long as the medication is in use. 
Medication induced acquired stuttering is based only in neurochemical irregularities or a 
disruption of neurophysiology due to neurochemical changes, while organic stuttering 
has been hypothesized to have a basis in neurochemical and neuroanatomical 
irregularities (Lundgren et al., 2010; Movsessian, 2005; Van Borsel, 2014). 
A variety of drugs have been reported to induce stuttering. Drugs linked to the 
inception of stuttering include antipsychotics such as Clozapine (Grover et al., 2012; 
Kumar, Kathpal, & Longshore, 2013; Murphy et al., 2015), Risperidone (Yadav, 2010), 
Bupropion (Fetterolf & Marceau, 2013), Sertraline (Christensen et al., 1996), and 
Lithium if given in toxic doses (Sabillo et al., 2012). In contrast, some of the same drugs 
have been used to treat developmental stuttering by decreasing stuttering severity, 
including Risperidone (Maguire, Riley, Franklin, & Gottschalk, 2000; Yadav, 2010). 
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In addition to psychiatric drugs, theophylline, a drug used to treat respiratory 
diseases has been documented to induce stuttering in individuals. The pathologies that 
result from theophylline are hypothesized to arise from malfunction of the motor cortex 
and white matter tracts that connect different cerebral areas. These malfunctions can lead 
to disruptions in the neurophysiology of speech motor areas and the motor cortex, 
resulting in stuttering (Gerard, Delecluse, & Robience, 1998; Movsessian, 2005; 
Rosenfield, McCarthy, McKinney, Viswanath, & Nudelman, 1994). 
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Associated Speech and Language Symptomatology of Acquired 
Stuttering 
 
Stuttering commonly occurs with other speech or language disorders. Disorders 
including aphasia, anomia, dysarthria, and apraxia have been associated with acquired 
stuttering. All types of acquired stuttering have been reported as related to comorbid 
symptoms. However, associated symptomatology most commonly occurs with 
neurogenic stuttering as compared to psychogenic or medicine induced stuttering because 
neurogenic trauma has the greatest propensity for trauma associated with multiple brain 
areas and brain functions (Attanasio, 1987; Rentschler et al., 1984; Theys et al., 2008; 
Van Borsel, 2002). Larger lesions and greater CNS trauma increase the likelihood of 
additional communication problems present with acquired stuttering (Helm et al., 1980; 
Krishnan & Tiwari, 2011; Theys et al., 2008). Associated symptoms of acquired 
stuttering differ from organic stuttering, which most commonly occurs with phonological 
disorders (Chang et al., 2008; Duffy & Baumgartner, 1997; Ntourou et al., 2011; Yairi, 
2006; Yaruss et al., 1998). 
Examining the flexible nature of associated speech and language disorders and 
acquired stuttering aids in assessing and treating acquired stuttering. The presence of 
disfluent speech does not necessitate an underlying fluency disorder; disfluencies may be 
present, though they may not be stuttering-like in nature and be more closely related to 
other speech or language disorders. Additionally, the course of treatment for acquired 
stuttering varies depending on comorbid symptomatology. Therefore, identifying any 
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associated symptoms or disorders during evaluation is important for therapeutic processes 
(Helm et al., 1980; Krishnan & Tiwari, 2011; Theys et al., 2008). 
Comorbid speech and language disorders may appear at the same time as 
stuttering appears, following an onset of neurogenic, psychogenic, or medicine induced 
trauma. Comorbid symptoms may also begin prior to stuttering but continue to occur 
simultaneously with stuttering (Van Borsel et al., 1998). Additionally, co-occurring 
speech or language problems may subside while stuttering does not improve, or stuttering 
may improve in the presence of abiding speech and language symptoms (Grant et al., 
1999).  
Aphasia is a language disorder that commonly occurs with acquired stuttering. 
Aphasia usually presents alongside acquired stuttering as either neurogenic stuttering 
related to neurological trauma or as psychogenic stuttering related to an emotional 
reaction to aphasia (Helm et al., 1980; Lundgren et al., 2010; Van Borsel, 2014). 
Different types of aphasia, including Broca’s, Wernicke’s, and conduction aphasia, have 
been reported to occur with acquired stuttering (Van Borsel, 2002). Aphasia of multiple 
types contributes additional non-stuttering like disfluencies (i.e. whole word repetitions, 
interjections, revisions) because of word finding or error correcting difficulties that 
happen alongside stuttering-like disfluencies (Farmer, 1975; Lundgren et al., 2010). 
Anomia, or word finding difficulties, is a language difficulty that can occur alone or with 
aphasia, and is reported in association with acquired stuttering. Broca’s aphasia and 
anomia tend to be associated with less severe stuttering, while Wernicke’s aphasia and 
conduction aphasia tend to be associated with more severe stuttering. Additionally, 
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people with aphasia and stuttering demonstrate more severe stuttering than those with 
only stuttering (Farmer, 1975). 
Broca’s aphasia is the most frequently reported associated language disorder to 
acquired stuttering. Broca’s area is in the left anterior portion of the brain, the same area 
of damage that is most commonly associated with acquired stuttering. Therefore, damage 
to this area of the brain leads to the possible manifestation of both Broca’s aphasia and 
acquired stuttering (Van Borsel, 2002). Individuals with Broca’s aphasia typically present 
with laborious speech, characterized by the production of slow, strained content words.  
These difficulties foster additional communication challenges for those who have 
concurrent acquired stuttering (Farmer, 1975; Lundgren et al., 2010).  
Wernicke’s aphasia is another aphasia type reported to occur with acquired 
stuttering. Wernicke’s aphasia is characterized by difficulties with comprehension and 
semantic content in language, despite typical grammar output. Paraphasias (production of 
unintended sounds, syllables, or words) and neologisms (made up words) commonly 
occur with Wernicke’s aphasia. Attempts to correct paraphasias or neologisms may 
present as disfluent speech, but should be considered as non stuttering-like disfluencies 
and different from co-occurring Wernicke’s aphasia and stuttering-like disfluencies 
(Farmer, 1975; Guitar, 2013; Van Borsel, 2014).  
Aphasia and anomia often have disfluencies related to the disorders because of 
word finding difficulties and linguistic errors. Word finding difficulties that create 
disfluencies should be distinguished from disfluencies that occur alongside, but separate 
from, aphasias and anomia. Additionally, repetitions during intentional correction of 
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linguistic errors are common in aphasia and anomia and should be distinguished from 
stuttering-like disfluencies. These can be distinguished from stuttering by looking at 
errors in sound production. Stuttering often occurs on the correct production of a sound, 
while repetitions of sounds, syllables, or words to correct errors occur deliberately on 
incorrect productions (Guitar, 2013; Van Borsel, 2014).  
Dysarthria co-occurring with acquired stuttering may add additional 
communication difficulties. Problems producing perceptually appropriate rate and 
volume of speech, alongside fluency difficulties, are common clinical presentations of 
those with acquired stuttering and dysarthria (Helm et al., 1980; Krishnan & Tiwari, 
2011; Theys et al., 2008). Dysarthria may cause a difficulty or inability to tap 
rhythmically or sing. This creates challenges in stuttering treatment, as treatment 
sometimes incorporates speaking while tapping and speaking with a particular rhythm 
(Helm et al., 1980; Krishnan & Tiwari, 2011; Theys et al., 2008). Similar to the 
presentation of most associated speech and language disorders, different dysarthria types 
occur with different lesion sites. Therefore, the dysarthric and disfluent characteristics 
may vary depending on the area and extent of trauma (Van Borsel et al., 1998). 
Apraxia is often associated with repetitions of sounds due to articulation and 
motor speech difficulties and can occur alongside acquired stuttering (Lundgren et al., 
2010). Apraxia may cause speech so sound slow and labored, creating additional 
communication difficulties for those with both acquired stuttering and apraxia. Acquired 
stuttering should be distinguished from repetitions that occur when an individual is trying 
to correct motor errors that occur because of apraxia. For example, disfluent speech may 
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occur because of multiple attempts to correctly articulate a sound by a person with 
apraxia, however these repetitions should be considered non-stuttering like disfluencies 
(Chang et al., 2008; Duffy & Baumgartner, 1997; Lundgren et al., 2010; Ntourou et al., 
2011; Yairi, 2006; Yaruss et al., 1998). 
Pallalia, a disorder that includes disfluencies from repetitions, should be 
distinguished from acquired stuttering. Pallalia is an extrapyramidal disease characterized 
by whole word, phrase, or sentence repetitions that are produced with increasing speed 
(i.e. “speech festination”; most commonly seen as a result of Parkinson’s disease) (Duffy 




Assessment of Acquired Stuttering 
 
 There is a strong link between neurogenic, psychogenic, and medicine induced 
stuttering, rendering the assessment process as challenging. The different types of 
acquired stuttering share common characteristics in clinical presentation and may be 
difficult to distinguish from one another. Furthermore, all three types of acquired 
stuttering can be interrelated. For example, a person who sustains a traumatic brain injury 
may have psychological stress associated with their recovery and may have to take 
medication to aid neurological and psychological trauma. Therefore, it is necessary to 
closely examine the case history and present disfluent characteristics to adequately assess 
and diagnose the individual (Helm et al., 1980). Additional complications arise from the 
possibility of a neurologic basis of stuttering that is exacerbated by increased stress or 
anxiety (Theys et al., 2008, 2009). Key diagnostic questions include asking about the 
time interval between any suspected or confirmed neurological or psychological trauma. 
Additionally, individuals should be asked if there were any significant environmental 
factors, including starting medication use, in the time period around the onset of 
stuttering (Theys et al., 2008).  
Motor disorders often accompany both neurogenic and psychogenic stuttering, 
and many individuals experiencing trauma have additional sensory and cognitive 
complaints. It is uncommon that a person does not present with other problems that 
accompany their disfluencies, adding to the difficulty of diagnosis and etiological 





GENERAL ASSESSMENT PROCEDURES 
 General assessment procedures should be administered when assessing any type 
of acquired stuttering. Gathering a detailed case history and family history of stuttering, 
language, or learning should be obtained for information on potential symptoms of 
developmental stuttering during childhood. The case history should also include fluency 
patterns, changes in fluency patterns over time, and any periods of time in which the 
individual was fluent. Stuttering is variable, a person may be fluent in one situation and 
stutter a lot in another, so information of their history of stuttering is essential. 
Additionally, information on the onset of stuttering is important to collect, such as the age 
it first occurred and if it occurred after an acute neurologic or psychogenic event, or after 
medication use (Guitar, 2013).  
Standard assessment procedures, like gathering a representative speech sample, 
finding a disfluency index, examining secondary behaviors, measuring speech rate, and 
assessing feelings and attitudes about stuttering, should be done during assessment of 
acquired stuttering. A motor speech examination should be given during the assessment 
to assess for motor speech disorders that may be influencing the disfluencies (Shipley & 
McAfee, 2016).  
 
NEUROGENIC STUTTERING ASSESSMENT 
Neurogenic stuttering assessment involves examining brain scans to confirm 
lesions or neurologic trauma. Confirmation of brain trauma around the same time as the 
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onset of stuttering is a strong diagnostic marker in assessing neurogenic stuttering 
(Sabillo et al., 2012). If a brain scan is not conducted, or if nothing remarkable is found 
on a scan, examinations to assess various cognitive abilities may indicate brain damage. 
Tasks should include probing for language expression and comprehension, memory, 
orientation, and attention to help identify presence of brain damage. Although rare, MRI 
scans have been reported to give false negative results. Therefore, additional cognitive 
testing may be warranted in suspected neurologic damage if brain scans report no damage 
(Ward, 2010). 
Response to Treatment: 
Neurogenic stuttering usually persists for a long time and responds poorly  to 
treatment (Tippett & Siebens, 1991; Van Borsel, 2002). Some neurogenic stuttering 
resolves with common stuttering treatment (i.e. counseling, fluency modification, fluency 
shaping), however like organic stuttering, improvements in fluency are widely variable. 
Additionally, stuttering improvement depends on the improvement of the underlying 
neurological problem. If the lesion site heals or is fixed, stuttering is more likely to 
resolve. However healing or fixing the lesion site typically takes a significant period of 
time, so a quick recovery is typically not observed in trial therapy during the assessment 
period (Ward, 2010). 
Associated Non-Speech-and-Langauge Symptomatology: 
Assessing non-speech-and-language associated symptomatology aids in 
evaluation. Confirming the presence of other problems, including headaches, right and 
left hemiparesis, tremor, and incoordination, contributes to the diagnosis of neurogenic 
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stuttering. These characteristics are more common among those with neurogenic 
stuttering than any other type of acquired stuttering (Duffy & Baumgartner, 1997; Theys 
et al., 2008).  
Related Characteristics: 
Neurogenic stuttering has been reported to include certain characteristics that are 
uncommonly present in organic stuttering or other forms of acquired stuttering. The 
following have been noted as possible diagnostic characteristics of neurogenic stuttering: 
disfluencies occuring on function words nearly as frequently as on content words; 2) the 
speaker does not appear anxious, however may exhibit negative emotions towards their 
stuttering; 3) repetitions, prolongations, and blocks occur on initial, medial, and final 
syllables of words and utterances; 4) secondary symptoms are not associated with 
moments of disfluency; 5) there is no adaptation effect; and 6) stuttering occurs relatively 
consistently across different types of speech tasks. There have been discrepancies in the 
literature regarding these characteristics. Some have been reported in psychogenic 
stuttering and organic stuttering, and they are not all always present in neurogenic 
stuttering. Though the characteristics may occur among a large percentage of neurogenic 
stuttering, the criteria should be used with caution because they are not always reliable 
(Krishnan & Tiwari, 2013; Theys et al., 2008; Ward, 2010).  
Stuttering typically occurs on content and function words in neurogenic stuttering. 
This differs from organic stuttering in which disfluencies most often occur on content 
words. This characteristic has largely been indicated in the literature and may aid in 
discriminating between neurogenic and organic stuttering, however this characteristic is 
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also reported in other types of acquired stuttering (Bloodstein, 1988; Guitar, 2013; Theys 
et al., 2008). 
Many individuals have been reported to show emotional reactions, like discontent 
or annoyance, despite the absence of anxious behaviors associated with stuttering. This 
supports the idea that they may be displeased with their communication in general but do 
not have anxiety symptoms associated with their stuttering (Ardila & Lopez, 1986; Helm 
et al., 1980; Krishnan & Tiwari, 2011; Theys et al., 2008; Tippett & Siebens, 1991). 
Accounts of individuals reporting or appearing to be anxious have been indicated, 
however, so this characteristic alone should not be used to determine neurogenic 
stuttering (Attanasio, 1987; Theys et al., 2008). 
Disfluencies have been noted in all syllable positions in neurogenic stuttering. 
They are most frequently reported to occur in the initial position and then the medial 
position. While final position disfluencies are present, they are not reported frequently in 
acquired neurogenic stuttering. Like the other diagnostic characteristics, this 
characteristic cannot be used in unison to diagnose neurogenic stuttering (Bloodstein, 
1988; Guitar, 2013; Theys et al., 2008). 
Assessment of secondary behaviors may yield evidence of neurogenic stuttering. 
Though there is debate in the literature on the relationship of secondary behaviors and 
neurogenic stuttering, behaviors such as facial tension and extraneous body movements 
are noted as less frequent in neurogenic stuttering than in organic stuttering. The presence 
of secondary behaviors should not negate the presence of neurogenic stuttering, however 
the absence of secondary behaviors offers a more concrete diagnosis of neurogenic 
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stuttering because the behaviors have been reported as absent in the majority of those 
with neurogenic stuttering (Helm et al., 1980; Theys et al., 2008; Van Borsel & Taillieu, 
2001). 
The adaptation effect is noted as variable among people with neurogenic 
stuttering. The majority of individuals with neurogenic stuttering do not show adaptation 
during multiple passage readings as they remain consistent after consecutive passage 
readings (Krishnan & Tiwari, 2013; Rentschler et al., 1984; Theys et al., 2008). A test for 
adaptation should be included during the assessment process. If no adaptation effect is 
present, neurogenic stuttering may be indicated. However the results should be applied to 
the evaluation with caution (Rentschler et al., 1984; Theys et al., 2008). 
Gathering speech samples from multiple tasks aids in neurogenic stuttering 
assessment. Those with acquired neurogenic stuttering have been observed to stutter in 
multiple speech tasks. Stuttering is generally noted to be relatively consistent among 
various communication tasks, including spontaneous speech samples and reading aloud. 
However as previously mentioned, each person who stutters has a unique profile and 
there are reports of people with acquired neurogenic stuttering that vary among speech 
tasks (Theys et al., 2008, 2009).  
The wide variety of characteristics present in acquired neurogenic stuttering leads 
to a difficult diagnostic task. Many of the characteristics vary greatly between 
individuals, so the most salient diagnostic marker is stuttering appearing shortly after a 
neurological injury. If stuttering occurs close to a neurological trauma, it is likely that the 
trauma caused stuttering and the stuttering is neurogenic in nature. If the stuttering occurs 
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a month or more after a neurological insult, it is difficult to link the initial injury and the 
onset of disfluencies. The patient should be asked the time interval between the 
neurological event and the onset of stuttering to aid the assessment process. Largely, the 
literature remains unresolved on concrete characteristics of acquired stuttering. The 
criteria of characteristics, therefore, is suggested as a guideline in assessing neurogenic 
stuttering rather than a strict rule of assessment (Helm et al., 1980; Krishnan & Tiwari, 
2013; Theys et al., 2008). 
 
PSYCHOGENIC STUTTERING ASSESSMENT 
Presence of psychological stress around the onset of stuttering is a significant 
diagnostic marker in psychogenic stuttering. If disfluencies begin near the time of a 
psychologically traumatic event, it is probable that the disfluencies are suggestive of 
psychogenic stuttering (Tippett & Siebens, 1991; Van Borsel, 2002). Additionally, if 
stuttering worsens during psychiatric behaviors (i.e. stuttering worsening during an 
anxiety attack), psychogenic stuttering is probable (Helm et al., 1980). Examining 
neurologic trauma that occurs with psychiatric trauma is an important part of the 
assessment procedure, however. If the onset of neurological trauma, psychological 
trauma, and stuttering all occur within the same time period, further factors must be 
assessed to determine the etiology of stuttering such as trial therapy, mental health 
testing, examination of secondary behaviors, and examining the adaptation effect (Duffy 
& Baumgartner, 1997; Guitar, 2013; Helm et al., 1980; Krishnan & Tiwari, 2013; Theys 
et al., 2009; Tippett & Siebens, 1991; Ward, 2010). 
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Response to Treatment: 
The strongest evidence of psychogenic etiology in acquired stuttering is the 
response to treatment, necessitating the use of trial therapy during the assessment period. 
Those with psychogenic stuttering are likely to respond to successful psychological 
treatment; with improved mental health, improvements in disfluency are likely. 
Disfluencies are likely to subside or recover completely with one or two behavioral 
therapy treatment sessions or with the use of psychiatric management strategies during 
therapy (Duffy & Baumgartner, 1997; Van Borsel, 2002). 
Behavioral therapy used during fluency assessments includes psychoeducation, 
techniques to improve emotions, and rewards. Psychoeducation about traumatic events, 
negative emotions, or destructive behaviors that the individual is experiencing are 
discussed at the beginning of therapy. The individual will be taught that emotions are 
temporary and can be changed. Decreasing negative emotions and destructive behaviors 
by fostering positive experiences, alternative constructive thoughts, and activities should 
be a main goal of behavioral therapy in fluency trial therapy. Finally, the individual 
should receive rewards, that can include praise or a physical object, for engaging in 
positive behavior (Courtois & Ford, 2009). Results of success with similar treatment 
approaches are seldom reported with neurogenic stuttering. Therefore, trying behavioral 
therapy during the assessment period is essential if psychogenic stuttering is suspected, as 
this is a strong diagnostic marker. This is not to say that all people with psychogenic 
stuttering will recover quickly with psychiatric therapy (Duffy & Baumgartner, 1997; 




A detailed psychiatric history should be obtained from the individual to assess for 
current mental health status. Mental health questions should relate to their overall mental 
health status and current level of stress in their life, relationships, and career. Questions 
may also be related to daily mood, sleep patterns, energy, orientation, and self harm 
thoughts. If the person is unable to participate in a mental health assessment, the person’s 
family members or close friends may answer the questions to the best of their ability 
(Krishnan & Tiwari, 2013). 
The absence of neurological factors is a further indication of psychogenic 
stuttering in adults with acquired stuttering. If brain scans are administered and the results 
indicate no neuropathology, yet stuttering is still present, this is suggestive that the 
stuttering is psychological in nature. Furthermore, if stuttering improves despite no 
neurological improves, psychogenic stuttering may be indicated (Guitar, 2013; Tippett & 
Siebens, 1991; Ward, 2010). Stuttering that emerges as a result of brain injury may be 
psychological in nature despite evidence of neurologic damage. Disfluencies can result as 
an emotional reaction to neurogenic disorders and therefore is best classified as 
psychogenic stuttering. It is important to distinguish disfluencies that arise as a symptom 
of an emotional reaction and as a symptom to a neurogenic disorder. A person with 
aphasia may present with disfluencies, likely to be non-stuttering like disfluencies (word 
and phrase repetitions, interjections, revisions), which do not result from psychological 
problems but result from word finding difficulties due to the aphasia. However, the same 
person may also experience stuttering like disfluencies (sound and syllable repetitions, 
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blocks, prolongations) that do result from psychological problems. If the person presents 
with stuttering like disfluencies, they should be assessed for psychogenic stuttering. In 
assessment of an individual with brain injury, diagnosticians can look for improvement in 
fluency despite absence of improvement in neurology (Guitar, 2013; Tippett & Siebens, 
1991; Van Borsel, 2014). 
Examining secondary behaviors is a further method of distinguishing between 
acquired fluency disorders when psychogenic stuttering is possible. The presence of clear 
muscular tension is often noted in those with psychogenic stuttering, but not commonly 
observed in those with neurogenic stuttering. There are also reports of “bizarre” 
behaviors in individuals with psychogenic stuttering, including agrammatic speech 
without the presence of aphasia, abnormal body movements (i.e. unusual grammatical 
deviations, multiple repetitions of all phonemes) and unusual struggle behaviors (i.e. 
tremor-like arm movements) during disfluent moments (Duffy & Baumgartner, 1997; 
Guitar, 2013; Lundgren et al., 2010; Van Borsel, 2002; Ward, 2010). 
The adaptation effect, or increased exposure to a stimulus leading to decreased 
anxiety regarding the stimulus, has been reported to help assess acquired stuttering 
(Starbuck & Steer, 1953). Psychogenic stuttering can be founded in anxiety disorders, 
therefore improvements have been noted in psychogenic stuttering with adaptation, both 
to situations and to reading passages, because of less perceived anxiety with each 
successive stimulus exposure (Theys et al., 2009). However, lack of success using the 
adaptation effect has also been reported in those with a psychogenic stutter. The 
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adaptation effect, therefore, should be used with caution when assessing the etiology of 
acquired stuttering (Helm et al., 1980; Starbuck & Steer, 1953; Theys et al., 2009). 
 
MEDICINE INDUCED STUTTERING ASSESSMENT 
Assessing suspected medicine induced stuttering requires a detailed profile of the 
individual, including medication history and history of any suspected neurological or 
psychological disorders. Acquired stuttering as a result of medication use is rare, so it is 
important to assess the profile of the person who stutters because stuttering may happen 
after drug use but stem from another cause. For example, if a person acquires a stutter 
after using a drug used to treat psychiatric disorders, the person must be examined to see 
if the cause of the stuttering is from psychogenic reasons or because of the drug used to 
treat the psychiatric disorder (Grover et al., 2012). Additionally, because acquired 
stuttering from drug use is rare, it is possible that the people with medication induced 
stuttering have a predisposition, or family history, of stuttering and the medication was a 
catalyst for stuttering (Yadav, 2010). 
Response to Treatment: 
Many of the drugs that may induce stuttering are of psychotherapeutic nature, it is 
therefore imperative to assess whether the drug of the psychiatric disorder is causing the 
stuttering. A reliable method of testing for this is manipulating the drug dosage, or 
discontinuing the drug, to see if disfluencies are impacted (Christensen et al., 1996; 
Grover et al., 2012; Murphy et al., 2015; Yadav, 2010). If the person is on multiple 
medications, especially if the person is on multiple medications that have shown 
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stuttering as a side effect, it is necessary to manipulate the medications independently and 
in unison to detect the drug related cause of the stuttering (Sabillo et al., 2012). For 
example, a person was assessed after a reported drug overdose from Tranxene, a 
Benzodiazepine used for treatment of psychiatric disorders. The person was noted to have 
manic-depression, anxiety, and previous suicide attempts. Because stuttering is a proven 
side effect of both psychological trauma and medication use, and the individual presented 
with psychiatric problems and used medication that has been associated with acquired 
stuttering, the individual must be assessed through medication manipulation (and 
possibly psychiatric behavioral therapy) to find the etiology (Rentschler et al., 1984).  
 
MALINGERED STUTTERING ASSESSMENT 
 Malingered stuttering is a type of stuttering that is conscious, intentional, and 
feigned by an individual. Malingered stuttering has not been mentioned in this report yet 
because it is not an authentic type of stuttering. Rather, a person fakes a stuttering 
disorder to gain benefit, either by obtaining something (i.e. obtaining insurance benefits) 
or by avoiding something (i.e. avoiding work responsibilities, avoiding accusation in 
criminal trial) (Shirkey, 1987; Van Borsel, 2014).  
Each person who stutters has unique disfluencies or stuttering behaviors, 
rendering malingered stuttering difficult to decipher and assess. Assessing for 
characteristics of both organic stuttering and acquired stuttering types further complicates 
deciphering authentic stuttering from malingered stuttering. Though specific disfluency 
characteristics are common among people who stutter and may be difficult for a non-
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stuttering individual to replicate, stuttering is idiosyncratic in nature and the possibility of 
uncommon characteristics in authentic stuttering exists. Therefore, it is difficult to assess 
malingered stuttering because there are no invariable diagnostic markers of stuttering that 
are true for every person who stutters (Bloodstein, 1988; Shirkey, 1987). 
 Malingered stuttering assessment includes a careful analysis of speech samples. 
Spontaneous speech, multiple readings of passages, and prolonged speech should be 
evaluated. Speech samples provide information on the position of stuttered sounds or 
words and the grammatical function of the words (content or function word) that are 
stuttered. Stuttering is generally most frequent on the initial sound or syllable of a word. 
Furthermore, stuttering usually appears on content words. Both of these qualities should 
be present in genuine stuttering. Multiple readings of passages are used to assess 
adaptation and consistency of disfluencies. The adaptation effect is common among those 
with organic stuttering and forms of acquired stuttering when they are given multiple 
opportunities to read the same passage. Additionally, those with organic stuttering tend to 
have consistent disfluencies, meaning they stutter on the same word when it is said on 
separate occasions. Prolonged speech, or elongating the duration of the sounds produced, 
is a beneficial strategy for stuttering that usually mitigates disfluencies. The presence of 
fluent speech when prolonged is a telling diagnostic marker of stuttering and should be 
included in assessing for malingered stuttering.  Presence and types of secondary 
characteristics can also be assessed during a speech sample by comparing them to 
common secondary behaviors in stuttering, including observable facial tension, eye 
blinking and extraneous body movements. Therefore, assessing speech samples for the 
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adaptation effect, stuttering consistency, the impact of prolonged speech, and secondary 
characteristics in suspected malingered stuttering are important facets of assessment 
(Bloodstein, 1988; Seery, 2005; Shirkey, 1987). 
 Family history, personal history, and interviews with people who know the 
individual who is stuttering are further assessment tools. Family history is evaluated to 
determine if a genetic component to stuttering is present. If a genetic component is 
present, there may be a smaller likelihood that the person is a malingered stutterer. 
Obtaining personal history, including school and medical records, provides information 
on the presence of stuttering during childhood or during a previous period of the 
individual’s life. The absence of stuttering mentioned in these reports does not 
necessarily reveal that the person is fluent and cannot in itself disprove stuttering. 
Furthermore, the person could have been a covert stutterer for a significant portion of 
their life, moderating the reference to stuttering in personal records. As such, records are 
an important component of stuttering assessment but should not stand alone in 
evaluation. Interviewing friends, family members, and acquaintances that know the 
individual provides a reference to compare, by examining symptoms that align or 
conflict, with the reports of the individual. An additional option is reviewing any 
previous voice or video recordings of the person to assess for similar disfluencies that are 
present at the time of evaluation (Bloodstein, 1988; Seery, 2005; Shirkey, 1987). 
Assessing speech difficulty and stuttering perception aids in malingered stuttering 
evaluation to further understand situations when the person has difficulty speaking and 
the attitudes and challenges related to their speech. Difficult situations commonly 
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reported by those who stutter are phone conversations, speaking to strangers, saying their 
name, and speaking in high anxiety situations (i.e., giving a presentation, talking to a 
person of the opposite gender). Assessing attitudes on communication allows for 
comparison of common emotions experienced during communication that are felt by 
people who stutter. Common emotions reported include anxiety in social situations that 
manifest through being silent, avoiding difficult words, and substituting difficult words 
for easier words. Sensations felt during stuttering are another evaluation area. Sensations 
commonly reported by those who stutter include tension in their face and “blocked” vocal 
chords despite knowing the word they want to say (Bloodstein, 1988; Shirkey, 1987).  
Examining the presence of stuttering qualities that are similar to a typical person 
who stutters, in most or all of the areas previously listed, assists in evaluating malingered 
stuttering. If a discrepancy in an area is found, the individual should be further assessed. 
No single trait can verify or refute stuttering, so gathering a comprehensive profile of the 
individual that includes the traits of typical stuttering contributes to a holistic assessment 
process. Furthermore, establishing malingered stuttering by inconsistencies found during 
the assessment process is more feasible than finding concrete evidence of malingered 






 Acquired stuttering is related to neurophysiological or neurochemical changes in 
the brain and appears independent of organic stuttering. Types of acquired stuttering 
include neurogenic stuttering, psychogenic stuttering, and medicine induced stuttering. 
Acquired stuttering is characterized by disfluent speech accompanied by differing 
secondary characteristics that depend upon the type of acquired stuttering and the 
individual. The onset of acquired stuttering is typically seen in adulthood, with few cases 
developing during childhood. However, any person with neurological trauma, 
psychological brain changes, or using medication may experience acquired stuttering. 
Differentiating between the three types of acquired stuttering may be a difficult task 
because neurological trauma, psychological stress, and medication use often coincide. 
Examining the circumstances around onset, the characteristics, and the response to 
treatment can lend beneficial information and evidence used to determine the etiology of 
stuttering (Duffy & Baumgartner, 1997; Krishnan & Tiwari, 2013; Theys et al., 2009; 
Van Riper, 1964). 
 Neurogenic stuttering appears subsequent to CNS damage. Different types of 
neurological trauma can cause stuttering, including traumatic brain injury, stroke, 
epilepsy, encephalitis, neurodegenerative disease, and tumors. Disfluency and secondary 
characteristics vary significantly among individuals with neurogenic stuttering. However, 
significant portions of individuals display disfluencies within a month of CNS trauma. 
The strongest diagnostic marker, therefore, is disfluency appearance close in time to 
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neurological trauma (Grant et al., 1999; Krishnan & Tiwari, 2013; Lebrun et al., 1990; 
Sabillo et al., 2012; Tippett & Siebens, 1991; Van Borsel, 2002). 
 Psychogenic stuttering is caused by psychological trauma or emotional stress. A 
person suspected of psychogenic stuttering should be evaluated for previous or current 
mental health problems. Mental health problems coinciding with the onset of stuttering 
suggest psychogenic stuttering. The most salient assessment process for psychogenic 
stuttering includes trial therapy. The individual should be treated with behavioral therapy 
during the trial therapy phase and the recovery should be noted. A significant 
improvement in disfluencies following behavioral therapy provides compelling evidence 
that the stuttering is psychological in nature (Duffy & Baumgartner, 1997; Theys et al., 
2009; Ward, 2010). 
 Medicine induced stuttering is rooted in the presence or excess of medication use. 
Neurochemical responses or changes in the brain due to medicine trigger disfluent 
speech. Medications that have been reported to induce stuttering include antipsychotic 
drugs and drugs used to treat respiratory infections. Medicine induced stuttering can be 
assessed through the manipulation of medication use. Disfluencies tend to parallel 
medication use; with increased medicine use, disfluencies increase and with decreased 
medicine use, disfluencies decrease (Christensen et al., 1996; Grover et al., 2012; 
Lundgren et al., 2010; Murphy et al., 2015; Van Borsel, 2014; Yadav, 2010). 
Associated speech and language symptomatology is frequently observed with 
acquired stuttering. Aphasia, dysarthria, and apraxia are common coexisting 
communication disorders that present alongside acquired stuttering. Co-occurring 
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communication disorders may impact overall communication effectiveness in an 
individual with acquired stuttering. Comorbid symptomatology differs among various 
presentation of acquired stuttering and relates to the specific neurological problems of the 
individual (Helm et al., 1980; Krishnan & Tiwari, 2011; Theys et al., 2008). 
Malingered stuttering is an intentional, feigned type stuttering that is used in order 
to benefit from a diagnosis of the disorder. Malingered stuttering assessment is a 
complicated, intricate process that includes comparing common stuttering characteristics 
seen in organic and acquired stuttering to the disfluency presentation of the individual 
suspected of malingered stuttering (Bloodstein, 1988; Seery, 2005; Shirkey, 1987). 
Acquired stuttering is a complex disorder composed of multifarious presentations 
and characteristics of disfluencies and behaviors. Understanding typical presentations of 
the types of acquired stuttering assists in the assessment process, and ultimately the 
treatment plan. A comprehensive view of the characteristics and assessment of acquired 
stuttering assists a speech-language pathologist in understanding the complex nature of 
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